modafinil will minimize the extent or outcome of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. modafinil will reduce the level or outcome of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. If coadministration with moderate CYP3A4 inducers is unavoidable, continue to administer fruquintinib at https://modafinil55421.blogolenta.com/23008172/little-known-facts-about-modafinil